March 2025
1. KINNAIRD A, Luger F, Cash H, Ghai S, et al
   Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial.
   JAMA. 2025 Mar 23:e253579. doi: 10.1001/jama.2025.3579.
   

   >> Share

   
   
2. RAYCHAUDHURI R, Lin DW, Montgomery RB
   Prostate Cancer: A Review.
   JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.0228.
   

   >> Share

   
   November 2024
3. AJJAWI I, Loeb S, Cooperberg MR, Catalona WJ, et al
   Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020.
   JAMA. 2024 Nov 20:e2420580. doi: 10.1001/jama.2024.20580.
   

   >> Share

   
   August 2024
4. TURNER EL, Metcalfe C, Martin RM
   PSA Screening and Prostate Cancer Mortality-Reply.
   JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13809.
   

   >> Share

   
   
5. GOLDSTEIN MR, Mascitelli L
   PSA Screening and Prostate Cancer Mortality.
   JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13806.
   

   >> Share

   
   
6. D'AMICO AV
   PSA Screening and Prostate Cancer Mortality.
   JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13803.
   

   >> Share

   
   July 2024
7. NIK-AHD F, De Hoedt AM, Butler C, Anger JT, et al
   Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.
   JAMA. 2024;332:335-337.
   

   >> Share

   
   June 2024
8. FENG X, Zahed H, Onwuka J, Callister MEJ, et al
   Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis.
   JAMA. 2024;331:1910-1917.
   

   >> Share

   
   May 2024
9. NEWCOMB LF, Schenk JM, Zheng Y, Liu M, et al
   Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
   JAMA. 2024 May 30. doi: 10.1001/jama.2024.6695.
   

   >> Share

   
   
10. HARRIS E
    Urine-Based Test Could Help Identify Aggressive Prostate Cancer.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.8424.
    

    >> Share

    
    
11. HARRIS E
    Prostate Cancer Cases Might Rise to 3 Million Globally by 2040.
    JAMA. 2024 May 3. doi: 10.1001/jama.2024.6729.
    

    >> Share

    
    April 2024
12. BAROCAS DA, Al Hussein Al Awamlh B, Koyama T
    Outcomes Following Localized Prostate Cancer Treatment-Reply.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5492.
    

    >> Share

    
    
13. HUANG TB, Ding XF
    Outcomes Following Localized Prostate Cancer Treatment.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5486.
    

    >> Share

    
    
14. CORNU JN
    Outcomes Following Localized Prostate Cancer Treatment.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5489.
    

    >> Share

    
    
15. AUVINEN A, Tammela TLJ, Mirtti T, Lilja H, et al
    Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.
    JAMA. 2024 Apr 6:e243841. doi: 10.1001/jama.2024.3841.
    

    >> Share

    
    
16. TOSOIAN JJ, Penson DF, Chinnaiyan AM
    A Pragmatic Approach to Prostate Cancer Screening.
    JAMA. 2024 Apr 6. doi: 10.1001/jama.2024.4089.
    

    >> Share

    
    
17. MARTIN RM, Turner EL, Young GJ, Metcalfe C, et al
    Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
    JAMA. 2024 Apr 6:e244011. doi: 10.1001/jama.2024.4011.
    

    >> Share

    
    January 2024
18. AL HUSSEIN AL AWAMLH B, Wallis CJD, Penson DF, Huang LC, et al
    Functional Outcomes After Localized Prostate Cancer Treatment.
    JAMA. 2024;331:302-317.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share